Edgar Raymond Wood, Iii

Title: Edgar Raymond Wood, III: Innovator in Cancer Treatment

Introduction

Edgar Raymond Wood, III is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of cancer treatment, holding a total of 6 patents. His work focuses on innovative methods and compounds that aim to improve therapeutic outcomes for patients suffering from cancer and related diseases.

Latest Patents

One of his latest patents is a cancer treatment method that describes the administration of a 4-quinazolineamine alongside at least one other anti-neoplastic agent. This method also includes a pharmaceutical combination featuring the 4-quinazolineamines. Another significant patent involves substituted oxindole derivatives as tyrosine kinase inhibitors. This invention relates to oxindole derivatives that are pharmacologically useful in treating disease states characterized by aberrant cellular proliferation, such as tumor growth, restenosis, atherosclerosis, pain, and thrombosis. The compounds developed in this patent exhibit Trk family protein tyrosine kinase inhibition, making them valuable in cancer therapy and chronic pain management.

Career Highlights

Throughout his career, Edgar has worked with prominent organizations, including SmithKline Beecham Corporation and SmithKline Beecham (Cork) Ltd. His experience in these companies has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Edgar has collaborated with notable professionals in his field, including Karen Elizabeth Lackey and Neil Lee Spector. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Edgar Raymond Wood, III is a distinguished inventor whose work in cancer treatment showcases his commitment to advancing medical science. His innovative patents and collaborations reflect his dedication to improving patient outcomes in the fight against cancer.